MMI (MEDICAL MICROINSTRUMENTS, INC.)

MMI Raises $110 Million in Series C Financing

Largest ever investment in microsurgery will further MMI’s mission to transform open surgery with robotic technology JACKSONVILLE, Fla.–(BUSINESS WIRE)–MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it has raised $110 million in Series C financing. The round, led by Fidelity Management & Research Company, marks the largest ever investment in … Continue reading MMI Raises $110 Million in Series C Financing

ZincFive

ZincFive Earns Finalist Spot in Esteemed 2024 Edison Awards™

Nickel-zinc battery technology earns industry excellence recognition in Resilient & Sustainable Solutions category PORTLAND, Ore.–(BUSINESS WIRE)–ZincFive®, the world leader in nickel-zinc (NiZn) battery-based solutions for immediate power applications, has been named a finalist in the 2024 Edison Awards™. The company is being honored in the Resilient & Sustainable Solutions category for its safe, reliable, powerful and sustainable nickel-zinc battery technology. @ZincFiveInc’s safe, reliable, powerful and sustainable … Continue reading ZincFive Earns Finalist Spot in Esteemed 2024 Edison Awards™

Mattel

Julius Genachowski and Dawn Ostroff Join Mattel Board of Directors

Mr. Genachowski previously served as Chairman of the FCC; Ms. Ostroff was Chief Content & Advertising Business Officer at Spotify EL SEGUNDO, Calif.–(BUSINESS WIRE)–Mattel, Inc. (NASDAQ: MAT) announced today that Julius Genachowski and Dawn Ostroff have joined the Company’s Board of Directors, effective February 5, 2024. The new Directors bring extensive combined experience in media, entertainment, and technology, and expertise in finance, M&A, and government … Continue reading Julius Genachowski and Dawn Ostroff Join Mattel Board of Directors

Gilead Sciences

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

— Gilead Adds Seladelpar to Portfolio, a PPARδ Agonist for the Treatment of Primary Biliary Cholangitis (PBC) with FDA Priority Review and Anticipated U.S. Approval in Third Quarter of 2024 — — Seladelpar Phase 3 Data Demonstrates a Best-in-Disease Profile for Second-Line PBC — — Acquisition Expands Gilead’s Long-Standing Commitment to Patients with Liver Diseases — February 12, 2024 08:30 AM Eastern Standard Time FOSTER … Continue reading Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Amplitude Vascular Systems

AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Global executive will lead the clinical research strategy and execution for pulse intravascular lithotripsy BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Elizabeth Galle as the company’s new Vice President of Clinical Affairs. She comes to AVS with more than two decades of leadership experience … Continue reading AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Cargill

Cargill becomes first global edible oils supplier to meet World Health Organization’s best practice on eliminating industrially produced trans-fatty acids

Meets 2021 commitment; removes iTFA from fats and oils even in countries without legislative mandates MINNEAPOLIS–(BUSINESS WIRE)–As of Jan. 1, 2024, every Cargill food customer, no matter where they are in the world, can be confident that the company’s fats and oils comply with the World Health Organization’s (WHO) recommended maximum tolerance level for industrially produced trans-fatty acids (iTFA) in fats and oils. Cargill has … Continue reading Cargill becomes first global edible oils supplier to meet World Health Organization’s best practice on eliminating industrially produced trans-fatty acids

Sanofi

Press Release: Peer support, flexible work arrangements, salary for a year: Sanofi launches global program for employees affected by cancer and critical illnesses

February 05, 2024 02:00 ET| Source: Sanofi – Aventis Groupe Peer support, flexible work arrangements, salary for a year: Sanofi launches global program for employees affected by cancer and critical illnesses Paris, February 5, 2024. Sanofi today launches ‘Cancer & Work: Acting Together’, a global program to support Sanofi employees whose lives are impacted by cancer and other critical illnesses. This program covers all Sanofi employees in … Continue reading Press Release: Peer support, flexible work arrangements, salary for a year: Sanofi launches global program for employees affected by cancer and critical illnesses

CroíValve

CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

Additionally, Martin B. Leon, M.D. Appointed as Chair of its Clinical Advisory Board DUBLIN–(BUSINESS WIRE)– CroíValve, an Irish-U.S. based medical device company with a novel, transcatheter solution for tricuspid regurgitation (TR), today announced initiation of its Early Feasibility Study (EFS) for the DUO™ Tricuspid Coaptation Valve System, following FDA IDE and CMS approval. The TANDEM II trial is a prospective, multi-center, non-randomized single-arm study to … Continue reading CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study